![](https://ml.globenewswire.com/media/c344b2ec-691c-494f-97bc-a81525c12457/small/orgenesis-jpg.jpg)
Orgenesis Announces Receipt of the $6.6 Million Second Milestone Payment into Masthercell Global Subsidiary
GERMANTOWN, Md., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services, as well as localized point-of-care development and …